Brief: Cleveland Biolabs Inc And Cytocom Announce Registration Statement And Proxy Statement For Previously Announced Merger Declared Effective By SEC
17/06/2021 23:41
June 17 (Reuters) - Cytocom:
* CLEVELAND BIOLABS INC AND CYTOCOM ANNOUNCE REGISTRATION
STATEMENT AND PROXY STATEMENT FOR PREVIOUSLY ANNOUNCED MERGER
DECLARED EFFECTIVE BY SEC
Source text for Eikon: ID:nPn6GXfywa
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc